Company Filing History:
Years Active: 1996-2000
Title: The Innovations of Benjamin G Neel
Introduction
Benjamin G Neel is a prominent inventor based in Wayland, MA (US). He has made significant contributions to the field of protein tyrosine phosphatases, holding a total of 3 patents. His work focuses on the development of novel mutants and peptides that have the potential to impact biological processes and medical treatments.
Latest Patents
One of his latest patents is titled "Activated mutants of SH2-domain-containing protein tyrosine phosphatases." This invention relates to novel mutant SH2 domain-containing protein tyrosine phosphatases that are partially or constitutively active. These mutants exhibit different regulatory abilities compared to wildtype protein tyrosine phosphatases. The invention also includes methods for using these mutants in in vitro assays to screen for binding partners and inhibitors, as well as in the treatment of diseases related to protein tyrosine phosphatases. Another significant patent is for a "Peptide which binds SH2 domains of protein tyrosine phosphatase." This patent describes novel assays for identifying agents that alter the effect of erythropoietin on the proliferation of erythroid cells, along with a novel peptide that comprises the erythropoietin receptor binding site for SH-PTP1.
Career Highlights
Throughout his career, Benjamin G Neel has worked with esteemed institutions such as Beth Israel Hospital and the Massachusetts Institute of Technology. His research has contributed to advancements in understanding protein interactions and their implications in various biological processes.
Collaborations
He has collaborated with notable individuals in his field, including Robert M Freeman, Jr and Jorge Plutzky. These collaborations have further enriched his research and innovations.
Conclusion
Benjamin G Neel's contributions to the field of protein tyrosine phosphatases through his patents and collaborations highlight his role as a significant inventor. His work continues to pave the way for advancements in medical research and treatment options.